PHILADELPHIA – Reducing albuminuria is a key mediator of the way finerenone (Kerendia, Bayer) reduces adverse renal and cardiovascular events in people with type 2 diabetes and […]

PHILADELPHIA – The 2021 Chronic Kidney Disease Epidemiology Collaboration race-free equation for calculating estimated glomerular filtration rate showed the least bias and most consistent performance, compared with two […]

PHILADELPHIA – A proprietary formula showed good performance stratifying the risk of adults with early-stage chronic kidney disease (CKD) advancing to more severe kidney dysfunction and increased health […]

PHILADELPHIA, Pennsylvania — Treatment with aprocitentan, a novel agent currently under Food and Drug Administration review for lowering blood pressure in people with treatment-resistant hypertension, showed […]

PHILADELPHIA – An electronic medical record alert to primary care physicians that their adult patients with type 2 diabetes were due for an albuminuria and renal-function […]

VANCOUVER, Canada — A new calculator that predicts short-term fracture risk at both 1 year and 3 years in patients on dialysis performed well in a […]

In April 2021, dapagliflozin (Farxiga) received a new indication from the US Food and Drug Administration (FDA) for slowing progression of chronic kidney disease (CKD) in […]

(Reuters) -The U.S. Food and Drug Administration (FDA) has approved Ardelyx’s drug to treat high phosphate levels in patients with chronic kidney disease (CKD), the company […]

ALICE SPRINGS (Reuters) – Three times a week, Rachel Napaltjarri, an Aboriginal woman suffering from end-stage kidney failure, receives lifesaving dialysis to cleanse her blood in […]